Skip to main content
OpenTrials
Completed

NCT Number: NCT02616978

Retrospective Study on the Use of CEFALY® Device During Migraine Attacks

This is an Internet survey to collect data on the use of the Cefaly device to treat migraine attacks in regular Cefaly users.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Migraine Brain Diseases Central Nervous System Diseases Headache Disorders Headache Disorders, Primary Migraine Disorders Nervous System Diseases

Sex eligibility

All sexes

Study type

Observational

About this study

About 1000 CEFALY users, having the device since more than one year and having reordered electrodes in the last year, will be invited to participate to an Internet survey. This survey contains at most 8 questions, and data will be collected completely anonymously. Questions concern the use or not of the CEFALY during migraine attacks, the number of treated attacks and the number and type of acute anti-migraine drugs that were avoided thanks to the use of the CEFALY.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects using Cefaly device regularly for more than a year identify by reordering of electrodes during the last year.
  • History of likely episodic or chronic migraine with or without aura diagnosed by a physician

Exclusion criteria

  • N/A

Treatment and study plan

Primary outcomes

  1. Monthly number of acute drug intake avoided when using Cefaly to treat a migraine attack

    Time frame: Maximum 1 year

    On average, mean number of anti-migraine acute drug intake avoided per month per patient in regular Cefaly users, based on self reported average monthly number of attacks and percentage of attacks treated successfully with the Cefaly

Secondary outcomes

  1. Proportion of Cefaly users that report using also the device to treat migraine attacks

    Time frame: Maximum 1 year

    Percentage of regular Cefaly users using the device to treat attacks

  2. Proportion of migraine attacks treated with the Cefaly device

    Time frame: Maximum 1 year

    Percentage of migraine attacks treated with the Cefaly device by the Cefaly users

  3. Proportion of migraine attacks for which the use of the Cefaly device generate a reduction of drug intake

    Time frame: Maximum 1 year

    Percentage of migraine attacks treated with the Cefaly device and for which the acute anti-migraine drug intake is reduced thanks to the Cefaly

Sponsors and collaborators

Lead sponsor

Cefaly Technology

Industry

Registry information

Important dates

Study start
2015
Primary completion
2015
Study completion
2015
First posted
Nov 30, 2015
Registry last updated
May 8, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.